Outcome after XXXX resection and reconstruction with a modular hemipelvic prostheses.

@entity530 @entity1 @entity281 @entity3
PURPOSE: The aim of this study was to evaluate the early clinical outcome of reconstruction with modular hemipelvic prostheses after @entity530 resection. METHODS: We retrospectively reviewed eight @entity1 between 2004 and 2007 who had periacetabular resections and reconstruction with a modular hemipelvic prosthetic system for @entity530 with a mean follow-up of 27 (range,10~54) months. Oncology outcome was assessed with survival rate, local recurrence rate, International Society of Limb Salvage (ISOLS) score and complications. Two @entity1 had types I and II (periacetabular and ilium) pelvic resections, three had types II and III (periacetabular and pubis) pelvic resections and three had type I , II and III (ilium, periacetabular and pubis) pelvic resections. Nobody received chemotherapy or radiotherapy. RESULTS: Five @entity1 were free of disease; three @entity1 died of disease. The overall survival rate was 62.5%. None had local recurrence, and 37.5% had @entity3 . The mean ISOLS score was 19.5. No one had deep @entity281 or dislocation. CONCLUSIONS: Reconstruction with a modular hemipelvic prosthetic system after periacetabular resection is a promising method because of the acceptable complication rate and satisfactory functional outcome.
